Product Categories
Country: | United States |
---|---|
Tel: | 781-+1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
GDC-0834 | C33H36N6O3S | 1133432-49-1 | Details |
Taurocholic acid sodium salt hydrate;Taurocholic Acid sodium hydrate;Sodium taurocholate hydrate | C26H46NNaO8S | 345909-26-4 | Details |
GDC-0927;SRN-927 | C28H28FNO4 | 1642297-01-5 | Details |
Pictilisib dimethanesulfonate;GDC-0941 2 MeSO3H salt;GDC-0941 dimethanesulfonate | C24H30N7O6S3 | 957054-33-0 | Details |
GDP-?α-D-?mannose disodium | C16H23N5Na2O16P2 | 148296-46-2 | Details |
GDP366 | C20H17N5OS | 501698-03-9 | Details |
Gefitinib-d8;ZD1839 D8;Gefitinib D8 | C22H24ClFN4O3 | 857091-32-8 | Details |
Gefitinib N-oxide | C22H24ClFN4O4 | 847949-51-3 | Details |
Gemcabene calcium;PD-72953 calcium | C16H32CaO5 | 209789-08-2 | Details |
Gemcabene;PD-72953 | C16H30O5 | 183293-82-5 | Details |
Gemfibrozil 1-O-β-glucuronide | C21H30O9 | 91683-38-4 | Details |
Gemilukast;ONO-6950 | C36H37F2NO5 | 1232861-58-3 | Details |
Genz-123346 | C52H82N4O14 | 943344-58-9 | Details |
Salbutamol;AH-3365;Albuterol | C13H21NO3 | 18559-94-9 | Details |
GENZ-882706;RA03546849 | C26H25N5O3 | 2070864-35-4 | Details |
Gepotidacin;GSK2140944 | C24H28N6O3 | 1075236-89-3 | Details |
Germacrene D | C15H24 | 23986-74-5 | Details |
GET73;GET 73;Gamma hydroxybutyric acid analogue | C13H16F3NO2 | 202402-01-5 | Details |
GFB-8438 | C16H14ClF3N4O2 | 2304549-73-1 | Details |
GF 15 | C23H21ClO6 | 888042-13-5 | Details |
GGTI-2418 | C23H31N5O4 | 501010-06-6 | Details |
GGTI298 | C27H33N3O3S | 180977-44-0 | Details |
Ginsenoside Ra3 | C59H100O27 | 90985-77-6 | Details |
Giredestrant;GDC-9545 | C27H31F5N4O | 1953133-47-5 | Details |
Doxycycline hydrochloride;Hyclate;Vibramycin;Doxylin | C22H25ClN2O8 | 10592-13-9 | Details |
GLPG0492 (R enantiomer);GLPG0492 R enantiomer | C19H14F3N3O3 | 1215085-93-0 | Details |
GLPG0492 | C19H14F3N3O3 | 1215085-92-9 | Details |
Gisadenafil besylate;UK 369003-26 | C29H39N7O8S2 | 334827-98-4 | Details |
GKA50 | C26H28N2O6 | 851884-87-2 | Details |
Gln-AMS | C15H22N8O8S | 209543-57-7 | Details |
GLP-1 receptor agonist 3 | C31H30FN5O4 | 2230200-09-4 | Details |
GLP-1 receptor agonist 4 | C51H44Cl2N4O6 | 1187061-62-6 | Details |
TT-OAD2 free base | C50H47Cl2N3O6 | 1246826-07-2 | Details |
GLP-1 receptor agonist 2 | C30H31ClFN5O4 | 2230197-64-3 | Details |
GLP-1 receptor agonist 1 | C48H48F2N10O5 | 2212020-52-3 | Details |
GLP-26 | C19H17F2N3O3 | 2133017-36-2 | Details |
Fenbendazole;Fenbendazol;Phenbendasol;Panacur | C15H13N3O2S | 43210-67-9 | Details |
GLPG1205 | C22H22N2O4 | 1445847-37-9 | Details |
IPN60090;GLS1-IN-1 | C24H27F3N8O3 | 1853164-83-6 | Details |
Glucagon receptor antagonists-1 | C29H34FNO2 | 503559-84-0 | Details |
Glucagon receptor antagonists-2 | C22H30FNO2 | 202917-18-8 | Details |
Glucagon receptor antagonists-3 | C22H30FNO2 | 202917-17-7 | Details |
Glucagon receptor antagonists-5 | C30H29ClF3N3O3 | 2200274-63-9 | Details |
Glucocorticoid receptor agonist | C20H20F4N2O2 | 1245526-82-2 | Details |
Glucokinase activator 1 | C27H20F2N2O7S2 | 1328987-85-4 | Details |
O6BTG-octylglucoside;Glucose-conjugated MGMT inhibitor | C24H34BrN5O7S | 382607-78-5 | Details |
Clindamycin phosphate;Clindamycin 2-phosphate;U-28508;Clindamycin 2-dihydrogen phosphate;NSC 618653 | C18H34ClN2O8PS | 24729-96-2 | Details |
GLUT4 activator 1 | C23H21FN4O3S | 2253733-37-6 | Details |
Glutaminase-IN-1;CB839 derivative | C26H24F3N7O3Se | 2247127-79-1 | Details |
Glutaminyl Cyclase Inhibitor 3 | C24H32N6O2S | 2092921-50-9 | Details |
Glutaminyl Cyclase Inhibitor 4 | C22H33N5O3 | 2376329-36-9 | Details |
Glutaminyl Cyclase Inhibitor 1 | C21H24FN3O2 | 2110449-60-8 | Details |
Glutaminyl Cyclase Inhibitor 2 | C19H20FN3 | 1884546-29-5 | Details |
Gly-β-MCA | C26H43NO6 | 66225-78-3 | Details |
Antibacterial compound 2 | C22H30FN5O6 | 170104-58-2 | Details |
Glyco-Obeticholic acid | C28H47NO5 | 863239-60-5 | Details |
Glycolic acid oxidase inhibitor 1 | C16H10BrNO3 | 77529-42-1 | Details |
Carbenicillin disodium;Sodium carbenicillin;BRL-2064 | C17H19N2NaO6S | 4800-94-6 | Details |
Glycosidase-IN-1 | C13H23NO5 | 170376-12-2 | Details |
Glycosidase-IN-2 | C13H23NO5 | 476310-39-1 | Details |
Glyoxalase I inhibitor free base | C21H29BrN4O8S | 174568-92-4 | Details |
Glyoxalase I inhibitor | C21H30BrClN4O8S | 221174-33-0 | Details |
GlyRS-IN-1 | C12H17N7O7S | 112921-11-6 | Details |
GlyT1 Inhibitor 1 | C22H21N5O2 | 1820934-93-7 | Details |
GNA002 | C42H55NO8 | 1385035-79-9 | Details |
GNE-0439 | C21H31NO3 | 1241902-40-8 | Details |
GNE-616 | C24H23F4N5O3S | 2349371-81-7 | Details |
Lidocaine hydrochloride;Xyloneural;Lidocaine HCL;Lidothesin;Lignocaine hydrochloride | C14H23ClN2O | 73-78-9 | Details |
GNE-8505 | C21H24F3N5O | 1620573-48-9 | Details |
GNE 220 | C25H26N8 | 1199590-75-4 | Details |
GNF-6231 | C24H25FN6O2 | 1243245-18-2 | Details |
GNF179 (Metabolite);GNF179 Metabolite | C14H16FN3 | 1310455-86-7 | Details |
GNF362 | C22H21F3N6 | 1003019-41-7 | Details |
GNF4877 | C25H27FN6O4 | 2041073-22-5 | Details |
GOAT-IN-1 | C18H13ClF3NO3S | 1452473-54-9 | Details |
Golotimod;SCV 07;Gamma-D-glutamyl-L-tryptophan | C16H19N3O5 | 229305-39-9 | Details |
Lidocaine Hydrochloride hydrate | C14H25ClN2O2 | 6108-05-0 | Details |
Diminazene Aceturate | C22H29N9O6 | 908-54-3 | Details |
Gosogliptin;PF-00734200;PF-734200 | C17H24F2N6O | 869490-23-3 | Details |
GPI-1046 | C20H28N2O4 | 186452-09-5 | Details |
GPR120 Agonist 1 | C20H12ClF6NO3S | 1628448-77-0 | Details |
GPR120 modulator 1 | C19H16ClNO4S | 1050506-75-6 | Details |
GPR120 modulator 2 | C20H18ClNO3S | 1050506-87-0 | Details |
GPR35 agonist 1 | C10H4BrN5O5 | 2079880-92-3 | Details |
GPR40 Activator 1 | C31H31NO3S | 1309435-60-6 | Details |
GPR40 Activator 2 | C28H29NO6S2 | 1312787-30-6 | Details |
GPR40/FFAR1 modulator 1 | C21H19N5O3 | 874755-26-7 | Details |
GPR40 agonist 1 | C27H30FN3O4 | 1853982-41-8 | Details |
Nifedipine;Procardia XL;Procardia;BAY-a-1040;Adalat | C17H18N2O6 | 21829-25-4 | Details |
GPR4 antagonist 1 | C27H37N5 | 1197879-16-5 | Details |
NE 52-QQ57 | C24H28N6O | 1401728-56-0 | Details |
GPR84 antagonist 8 | C23H23N3O5 | 1445846-30-9 | Details |
GR 103691 | C30H35N3O3 | 162408-66-4 | Details |
GRL0617 | C20H20N2O | 1093070-16-6 | Details |
Lenacapavir;GS-6207 | C39H32ClF10N7O5S2 | 2189684-44-2 | Details |
GSK-2793660 | C20H27N3O3 | 1613458-70-0 | Details |
GSK-3β inhibitor 1 | C14H10N2O | 187325-53-7 | Details |
GSK-3 inhibitor 1 | C22H17ClFN5O2 | 603272-51-1 | Details |
GSK-3484862 | C19H19N5OS | 2170136-65-7 | Details |
Chlorhexidine dihydrochloride;Chlorhexidine 2HCl;NSC-185;Chlorhexidine hydrochloride | C22H32Cl4N10 | 3697-42-5 | Details |
Product Total: Product Page: | ||||
5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 |